According to a new analysis conducted by Alzheimer’s Research UK one in three people born in 2015 will develop Alzheimer’s Disease (AD) during their lifetime. The results suggest an alarming crisis in national health as the population in the United Kingdom ages, and highlights the demand for global efforts to develop new successful…
In a newly published paper in Genes & Development journal entitled “Myxococcus CsgA, Drosophila Sniffer, and human HSD10 are cardiolipin phospholipases“, researchers from University of Georgia suggest that a soil bacterium protein named HSD10 reduces oxidative stress, stimulates repair of nerve cells and contributes to slow down…
Results from a recent study showed that women are more likely to not only be diagnosed with Alzheimer’s Disease (AD), but to also be more heavily burdened by the associated economic costs, compared to men. The study, entitled, “Gender Differences: A Lifetime Analysis of the Economic Burden of…
A recent study published this week in Nature has revealed that the “seeds” of Alzheimer’s disease and related brain disorders may be transmitted by direct tissue transplantation. The results from the study entitled “Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy”, coupled with…
Results from the largest nationwide study investigating long-term high-dose resveratrol in patients with mild to moderate Alzheimer’s disease (AD) showed that a specific a biomarker that declines with disease progression was stabilized in patients who received resveratrol in its purified form. The results, published online in Neurology,…
In a new study entitled “Human umbilical cord blood-derived monocytes improve cognitive deficits and reduce ß-amyloid pathology in PSAPP mice” an international team of scientists showed that infusion of human umbilical cord blood cells (HUCBCs) into a mice model of Alzheimer’s disease improves animals’ cognitive performance by clearing amyloid-beta (Aβ)…
A new study from Michigan State University which aims to pinpoint the early signs of Alzheimer’s disease among Latinos and Hispanics, recently received a 5-year research grant from the National Institute on Aging worth $5.67 million. “Current thinking is it takes decades for Alzheimer’s disease to develop, so we are turning the…
In a new study entitled “Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer’s Disease Prevention and Early Intervention” researchers reported a breakthrough discovery when they showed ApoE2 human protein is a…
New research presented during the 14th International Conference on Endothelin: Physiology, Pathophysiology and Therapeutics, focused on the effects of IRL-1620 in a rat model of Alzheimer’s disease (AD). The compound, which acts on the endothelin B (ETB) receptor, reduced learning and memory deficits and oxidative stress in the animals, showing potential as an AD…
A gene signature that could be used to predict the onset of diseases, such as Alzheimer’s, years in advance has been developed in a study published in the open access journal Genome Biology. The objective of the study, entitled “A novel multi-tissue RNA diagnostic of…
Get regular updates to your inbox.